Publication | Closed Access

Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model

Anti-4-1bb-based ImmunotherapyAllergyAutoimmune DiseaseInsulin ManagementDiabetesImmunologyAutoimmunityTransgenic Non-obese DiabeticDiabetes MellitusInsulin DeliveryImmunotherapyMedicineInsulin SignalingAutoimmune Diabetes